Evidence map›Paper›PMID 41409524›Full record

ReviewFrontiers in chemistry2025

Green chemistry strategies in pulping and biomass valorization: toward a circular bioeconomy.

Neha Sharma, Priyanka Basera

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Neha SharmaIFM Institute of Frontiers Material, Deakin University, Geelong, VIC, Australia.
Priyanka BaseraEnvironmental and Industrial Biotechnology Division (EIBD), The Energy and Resources Institute (TERI), New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transition toward a circular bioeconomy demands innovative, sustainable, and efficient technologies for biomass valorization and pulping. Green chemistry strategies, particularly organosolvent pulping pretreatment, are emerging as pivotal solutions to unlock the full potential of lignocellulosic feedstocks. Organosolvent processes employ environmentally benign solvents to selectively fractionate biomass components, enabling the recovery of high-purity cellulose, hemicelluloses, and lignin with minimal environmental footprint. These technologies advance the principles of green chemistry by minimizing hazardous reagents, reducing energy consumption, and promoting waste valorization. Recent developments demonstrate their capacity not only to improve pulping efficiency but also to produce value-added chemicals, biomaterials, and biofuels, thereby closing resource loops and reducing reliance on fossil-based systems. This review uniquely integrates advances in organosolvent pulping pretreatment within the framework of green chemistry and circular bioeconomy. This work systematically compares multiple green solvent systems including ionic liquids, deep eutectic solvents, and bio-derived organosolvent methods alongside catalytic, biocatalytic, and process intensification techniques. It also synthesizes recent industrial case studies, bridging the gap between laboratory research and pilot-to-commercial scale deployment. By highlighting the synergistic role of these technologies in achieving high-purity biomass fractionation with minimal environmental footprint, the review provides actionable insights for researchers, policymakers, and industry stakeholders aiming to accelerate the transition to a regenerative, circular bioeconomy.

Indexed as

circular bioeconomyefficient technologiesgreen chemistryorganosolvent processsustainable strategies

Identifiers

PMID41409524
PMCPMC12705535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.